Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis

Article information

Korean J Pediatr. 2013;56(6):269-269

Publication date (electronic) : 2013 June 21

doi : https://doi.org/10.3345/kjp.2013.56.6.269

Won Seop Kim, MD

Department of Pediatrics, Chungbuk National University, College of Medicine, Cheongju, Korea.

Korean J Pediatr 2011;54:241-5.

http://dx.doi.org/10.3345/kjp.2011.54.6.241. PMID: 21949518 [PubMed]

The following article is being retracted as a part of the manuscript was plagiarized.

Yeong-Ho Rha, MD, PhD

Editor-in-Chief,

Korean J Pediatr

References

1. Kim WS. Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis. Korean J Pediatr 2011;54:241–245. 21949518.

Article information Continued

(open-access, http://creativecommons.org/licenses/by-nc/3.0/) :

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.